SCHEMBL20109133

SCHEMBL20109133

CC/C(=C\c1ccccc1)P1(=O)N(c2ccccc2)CCN1c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
USP2 O75604 1/20 0.40
ALOX15 P16050 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
KDM1A O60341 1/20 0.37
MAPT P10636 3/20 0.36
NPC1 O15118 1/20 0.36
KDM4E B2RXH2 1/20 0.36
NR1I2 O75469 1/20 0.35
AKR1C3 P42330 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
LMNA P02545 2/20 0.34
HPGD P15428 2/20 0.34
CHRM1 P11229 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109139 0.86 MAPT (0.36) TSHRSMN1; SMN2USP2ALOX15MEN1
SCHEMBL20109138 0.86 MAPT (0.36) TSHRSMN1; SMN2USP2ALOX15MEN1
SCHEMBL17596818 0.84 RECQL (0.42) TSHRSMN1; SMN2USP2ALOX15MEN1
SCHEMBL17596822 0.84 RECQL (0.42) TSHRSMN1; SMN2USP2ALOX15MEN1
SCHEMBL20109141 0.84 CHRNA7 (0.33) TSHRSMN1; SMN2USP2ALOX15MEN1
SCHEMBL20109330 0.83 MEN1 (0.46) SMN1; SMN2MEN1KMT2AALDH1A1MAPT
SCHEMBL20109235 0.82 SMN1; SMN2 (0.40) TSHRSMN1; SMN2USP2ALOX15MEN1
SCHEMBL20109140 0.75 CHRNA7 (0.36) TSHRALOX15MEN1KMT2AALDH1A1
SCHEMBL17595812 0.75 RBP4 (0.35) SMN1; SMN2USP2MEN1KMT2AALDH1A1
SCHEMBL17595815 0.75 RBP4 (0.35) SMN1; SMN2USP2MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 TSHR 4125/4885SMN1; SMN2 3047/4885USP2 4368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.